NDRA Stock Summary and Trading Ideas (Endra Life Sciences | NASDAQ:NDRA)

ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.

Endra Life Sciences trades on the NASDAQ stock market under the symbol NDRA.

As of April 24, 2026, NDRA stock price declined to $4.97 with 5,501 million shares trading.

NDRA has a beta of 3.23, meaning it tends to be more sensitive to market movements. NDRA has a correlation of 0.08 to the broad based SPY ETF.

NDRA has a market cap of $6.17 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, NDRA traded as high as $4,882.50 and as low as $2.90.

The top ETF exchange traded funds that NDRA belongs to (by Net Assets): VXF.

NDRA has underperformed the market in the last year with a price return of +31.5% while the SPY ETF gained +34.7%. However, in the short term, NDRA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +11.7% vs +3.8% return in SPY. But in the last 2 weeks, NDRA shares have been beat by the market, returning -6.4% compared to an SPY return of +5.0%.

NDRA support price is $4.50 and resistance is $5.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NDRA shares will trade within this expected range on the day.